Hexagon Capital Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-283
Closed -$12K 1469
2023
Q2
$11.9K Buy
283
+69
+32% +$2.79K ﹤0.01% 698
2023
Q1
$7.62K Buy
214
+50
+30% +$1.81K ﹤0.01% 798
2022
Q4
$6.02K Buy
+164
New +$6.48K ﹤0.01% 868

Other funds holding SYNH

Hexagon Capital Partners's SYNH Position: Q3 2023 in Review

Hexagon Capital Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 283 shares — an estimated $12K sold.

Hexagon Capital Partners first reported a position in SYNH in Q4 2022 and held it in 3 quarters. The position peaked at $11.9K in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Hexagon Capital Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Hexagon Capital Partners sold 283 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $12K.
  • Hexagon Capital Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2022 and held it in 3 quarters.
  • Hexagon Capital Partners's Syneos Health, Inc. Class A Common Stock position peaked at $11.9K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Hexagon Capital Partners's 13F filing for Q3 2023, filed 23 Oct 2023.